iifl-logo-icon 1

Oxygenta Pharmaceutical Ltd Share Price

32.14
(5.00%)
Jul 16, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open32.14
  • Day's High32.14
  • 52 Wk High52.27
  • Prev. Close30.61
  • Day's Low31.14
  • 52 Wk Low25.02
  • Turnover (lac)1.26
  • P/E0
  • Face Value10
  • Book Value-4.77
  • EPS0
  • Mkt. Cap (Cr.)114.04
  • Div. Yield0
No Records Found

Oxygenta Pharmaceutical Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

32.14

Prev. Close

30.61

Turnover(Lac.)

1.26

Day's High

32.14

Day's Low

31.14

52 Week's High

52.27

52 Week's Low

25.02

Book Value

-4.77

Face Value

10

Mkt Cap (₹ Cr.)

114.04

P/E

0

EPS

0

Divi. Yield

0

Oxygenta Pharmaceutical Ltd Corporate Action

23 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

4 Sep 2023

12:00 AM

AGM

Announcement Date: 04 Sep, 2023

arrow

8 Apr 2024

12:00 AM

EGM

arrow

Oxygenta Pharmaceutical Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Oxygenta Pharmaceutical Ltd SHAREHOLDING SNAPSHOT

17 Jul, 2024|07:44 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 33.68%

Foreign: 0.00%

Indian: 33.68%

Non-Promoter- 0.03%

Institutions: 0.02%

Non-Institutions: 66.28%

Custodian: 0.00%

Share Price

Oxygenta Pharmaceutical Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

14.2

14.2

10.2

10.2

Preference Capital

0

0

0

0

Reserves

-60.4

-48.83

-48.22

-51.15

Net Worth

-46.2

-34.63

-38.02

-40.95

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2020Mar-2019Mar-2018Mar-2017

Revenue

13.71

20.5

12.86

8.15

yoy growth (%)

-33.11

59.34

57.82

-34.37

Raw materials

-15.58

-16.07

-9.93

-5.63

As % of sales

113.6

78.4

77.17

69.1

Employee costs

-2.49

-3.2

-3.35

-3.31

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2020Mar-2019Mar-2018Mar-2017

Profit before tax

-9.92

-3.49

-4.47

-5.72

Depreciation

-0.99

-1.01

-0.94

-0.9

Tax paid

0.15

0.23

-0.04

-0.08

Working capital

-1

5.04

-2.12

3.97

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2020Mar-2019Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-33.11

59.34

57.82

-34.37

Op profit growth

285.21

-48.9

-17.46

16.26

EBIT growth

221.53

-23.19

-30.22

2.73

Net profit growth

77.87

-28.13

-22.05

5.62

View Ratios

No Record found

Oxygenta Pharmaceutical Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,579.25

124.153,78,914.98867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,511.35

32.861,22,044.231,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,564.95

76.931,21,185.085310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,184.85

34.691,19,223.631,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,643.15

25.871,10,827.471,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Oxygenta Pharmaceutical Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Sai Sudhakar Vankineni

Independent Director

D Vidya Sagar

Director (Technical)

Muralidhar R

Independent Director

Sangari Kondal Reddy

Independent Director

Padmaja Surapureddy

Executive Director

Kanuganti Raghavender Rao

Additional Director

Sravani Reddy Gantla

Additional Director

Bharath Reddy Guntuku

Company Sec. & Compli. Officer

Dolly Mandhan

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 2021-22.The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs. The Company is doing contract manufacturing work for APL and also having its own production. The Company is engaged in manufacture of bulk drugs. It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs. The Company has plant located at Medak in Andhra Pradesh. The Company has been doing contract manufacturing work with APL for manufacturing of Cirprofloxacin HCL from Q-Acid and has been manufacturing Pantaprozole Sodium and Gabapentine for own production. To minimize the working capital requirement and to have consistent income, it is necessary to continue contract manufacturing work till the Company gets working capital limits from any Bank. This contract manufacturing helps it to meet major operational expenses of the Company. Since the Company started commercial production in July, 2015 after fire accident, it is in the process of stabilizing the manufacturing and marketing.
Read More

Company FAQs

What is the Oxygenta Pharmaceutical Ltd share price today?

Down Arrow

The Oxygenta Pharmaceutical Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹32.14 today.

What is the Market Cap of Oxygenta Pharmaceutical Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Oxygenta Pharmaceutical Ltd is ₹114.04 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of Oxygenta Pharmaceutical Ltd?

Down Arrow

The PE and PB ratios of Oxygenta Pharmaceutical Ltd is 0 and -6.74 as of 16 Jul ‘24

What is the 52 Week High and Low of Oxygenta Pharmaceutical Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Oxygenta Pharmaceutical Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Oxygenta Pharmaceutical Ltd is ₹25.02 and ₹52.27 as of 16 Jul ‘24

What is the CAGR of Oxygenta Pharmaceutical Ltd?

Down Arrow

Oxygenta Pharmaceutical Ltd's CAGR for 5 Years at 32.74%, 3 Years at 49.75%, 1 Year at -23.05%, 6 Month at -8.15%, 3 Month at -16.35% and 1 Month at -12.28%.

What is the shareholding pattern of Oxygenta Pharmaceutical Ltd?

Down Arrow

The shareholding pattern of Oxygenta Pharmaceutical Ltd is as follows:
Promoters - 33.69 %
Institutions - 0.03 %
Public - 66.29 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.